SANTA CRUZ, Calif., Oct. 1, 2024 /PRNewswire/ — Fullpower-AI®, in collaboration with Stanford University and UCSF, is proud to announce the results of a landmark study presented at the recent European Sleep Conference in Seville, Spain. This study, leveraging the Sleeptracker-AI® platform, represents the largest-ever population-based assessment of sleep duration and architecture, analyzing over 7 million nights of sleep data.
Key Findings are:
Age-Specific Insights:
“This study provides crucial baseline data for understanding sleep patterns across the lifespan and the impact of sleep disorders,” said Philippe Kahn, Founder and CEO of Fullpower-AI®. “It underscores the importance of the 7-hour sleep recommendation and highlights how conditions like sleep apnea can significantly impact sleep quality.”
The scale and depth of this research mark a significant advancement in sleep science. These findings may shape future research and clinical practice in sleep medicine.
For more information about the study or to access detailed data, please visit sleeptracker.com.
About Fullpower-AI®
Fullpower-AI® designs, develops, and operates the Sleeptracker-AI® platform worldwide, targeting clinical trials and medical practitioners. Integrated into market-leading Tempur-Pedic smart beds, our platform offers clinical-grade accuracy comparable to gold-standard PSG.
For further details or media inquiries, contact busdev@fullpower.com
SOURCE Fullpower
BOSTON, April 21, 2025 /PRNewswire/ -- Onsite Mammography ("Onsite") announces a data incident that impacted…
New data demonstrates effectiveness of SPLENDOR X™'s dual-wavelength simultaneous laser emission technology for improved hair…
"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…
NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…
Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…
COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP)…